600781 Stock Overview
FUREN Group Pharmaceutical Co., Ltd. primarily engages in the manufacture and distribution of pharmaceuticals in Henan Province and Shanghai, China. More details
Snowflake Score | |
---|---|
Valuation | 4/6 |
Future Growth | 0/6 |
Past Performance | 0/6 |
Financial Health | 2/6 |
Dividends | 0/6 |
My Notes
Capture your thoughts, links and company narrative
FUREN Group Pharmaceutical Co.,Ltd. Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | CN¥0.77 |
52 Week High | CN¥3.65 |
52 Week Low | CN¥0.51 |
Beta | 0.61 |
1 Month Change | -8.33% |
3 Month Change | -34.19% |
1 Year Change | n/a |
3 Year Change | -79.30% |
5 Year Change | -95.02% |
Change since IPO | -66.52% |
Recent News & Updates
Recent updates
Shareholder Returns
600781 | CN Pharmaceuticals | CN Market | |
---|---|---|---|
7D | 0% | -1.9% | -1.2% |
1Y | n/a | -1.8% | 11.8% |
Return vs Industry: Insufficient data to determine how 600781 performed against the CN Pharmaceuticals industry.
Return vs Market: Insufficient data to determine how 600781 performed against the CN Market.
Price Volatility
600781 volatility | |
---|---|
600781 Average Weekly Movement | 16.5% |
Pharmaceuticals Industry Average Movement | 7.4% |
Market Average Movement | 8.7% |
10% most volatile stocks in CN Market | 12.8% |
10% least volatile stocks in CN Market | 5.7% |
Stable Share Price: 600781's share price has been volatile over the past 3 months.
Volatility Over Time: 600781's weekly volatility has increased from 10% to 17% over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
1996 | 2,916 | n/a | www.shfuren.cn |
FUREN Group Pharmaceutical Co., Ltd. primarily engages in the manufacture and distribution of pharmaceuticals in Henan Province and Shanghai, China. The company produces traditional Chinese medicines, such as capsules, tablets, granules, injections, eye drops, oral liquids, cream, and others. The company was formerly known Shanghai Minfeng Industrial (Group) Co., Ltd.
FUREN Group Pharmaceutical Co.,Ltd. Fundamentals Summary
600781 fundamental statistics | |
---|---|
Market cap | CN¥482.91m |
Earnings (TTM) | -CN¥2.75b |
Revenue (TTM) | CN¥1.58b |
0.3x
P/S Ratio-0.2x
P/E RatioIs 600781 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
600781 income statement (TTM) | |
---|---|
Revenue | CN¥1.58b |
Cost of Revenue | CN¥783.59m |
Gross Profit | CN¥798.23m |
Other Expenses | CN¥3.55b |
Earnings | -CN¥2.75b |
Last Reported Earnings
Mar 31, 2023
Next Earnings Date
n/a
Earnings per share (EPS) | -4.39 |
Gross Margin | 50.46% |
Net Profit Margin | -174.14% |
Debt/Equity Ratio | -144.8% |
How did 600781 perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
Data | Last Updated (UTC time) |
---|---|
Company Analysis | 2023/06/28 12:41 |
End of Day Share Price | 2023/06/19 00:00 |
Earnings | 2023/03/31 |
Annual Earnings | 2022/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
Package | Data | Timeframe | Example US Source * |
---|---|---|---|
Company Financials | 10 years |
| |
Analyst Consensus Estimates | +3 years |
|
|
Market Prices | 30 years |
| |
Ownership | 10 years |
| |
Management | 10 years |
| |
Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
FUREN Group Pharmaceutical Co.,Ltd. is covered by 1 analysts. of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
Analyst | Institution |
---|---|
Shuchang Liu | Changjiang Securities Co. LTD. |